Detalhe da pesquisa
1.
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452207
2.
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Ann Hematol
; 103(3): 759-769, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273140
3.
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer.
Clin Infect Dis
; 76(4): 674-682, 2023 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35906831
4.
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study.
Blood
; 137(20): 2827-2837, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33881523
5.
A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia.
Blood
; 137(4): 524-532, 2021 01 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32871585
6.
Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia.
Blood
; 135(8): 542-546, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31880804
7.
Kinetics of early and late molecular recurrences after first-line imatinib cessation in chronic myeloid leukemia: updated results from the STIM2 trial.
Haematologica
; 107(12): 2859-2869, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35615931
8.
Minimal residual disease monitoring in acute myeloid leukemia with non-A/B/D-NPM1 mutations by digital polymerase chain reaction: feasibility and clinical use.
Haematologica
; 106(6): 1767-1769, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33299234
9.
Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.
Haematologica
; 106(7): 1867-1875, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32527951
10.
Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial.
Eur J Haematol
; 107(1): 111-121, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765335
11.
Association of uric acid levels before start of conditioning with mortality after allogeneic hematopoietic stem cell transplantation - a prospective, non-interventional study of the EBMT Transplant Complication Working Party.
Haematologica
; 105(7): 1977-1983, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31601686
12.
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Ann Hematol
; 99(8): 1855-1862, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564196
13.
Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients.
Br J Clin Pharmacol
; 86(8): 1550-1559, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073158
14.
Outcomes of Salvage Haploidentical Transplant with Post-Transplant Cyclophosphamide for Rescuing Graft Failure Patients: a Report on Behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy.
Biol Blood Marrow Transplant
; 25(9): 1798-1802, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31129355
15.
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial.
Haematologica
; 104(1): 113-119, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076173
16.
Post-transplant cyclophosphamide in acute leukemia patients receiving more than 5/10 HLA-mismatched allogeneic hematopoietic cell transplantation from related donors: A study on behalf of the ALWP of the EBMT.
Am J Hematol
; 98(2): E41-E44, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36398703
17.
A Time-Dependent Model Describes Methotrexate Elimination and Supports Dynamic Modification of MRP2/ABCC2 Activity.
Ther Drug Monit
; 39(2): 145-156, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28196047
18.
Randomized, phase 2 trial of low-dose cytarabine with or without volasertib in AML patients not suitable for induction therapy.
Blood
; 124(9): 1426-33, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25006120
19.
Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors.
Biol Blood Marrow Transplant
; 21(5): 860-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25617807
20.
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
Eur J Haematol
; 94(3): 265-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25130897